Are you a new member? Sign up now
Login area
| Sign up
close
GENEPLATIN - 5mg/ml - 1 x 20ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XA03 | G | Oxaliplatin - 100mg/20ml | 9202 | 80316/1 | GENEPLATIN | 5mg/ml | 1 x 20ml | Injectable concentrate for solution | Infusion | Nobel Pharm Plus SARL | Genepharm SA | Greece | 2,974,540 L.L | 23.08 | B | Genepharm SA | Greece | 2/1/2023 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XA03 | G | Oxaliplatin - 100mg/20ml | 6455 | 166989/11 | OXALIPLATIN EBEWE | 100mg/20ml | 1 x 20ml | Injectable concentrated solution | Infusion | Khalil Fattal & Fils S.A.L. | Ebewe Pharma GesmbH.NFG.KG | Austria | 5,610,582 L.L | 21.26 | C | Ebewe Pharma GesmbH.NFG.KG | Austria | 2/1/2023 |
| L01XA03 | G | Oxaliplatin - 100mg/20ml | 5838 | 219300/09 | OXALIPLATIN HOSPIRA | 5mg/ml | 1 x 20ml | Injectable concentrated solution | Infusion | Food & Drug Corporation FDC | Hospira UK Ltd | UK | 5,772,664 L.L | 21.26 | C | Hospira UK Ltd | UK | 2/1/2023 |
| L01XA03 | G | Oxaliplatin - 100mg | 8488 | 99515/1 | OXALIPLATIN MEDAC | 100mg | 1 | Injectable powder for solution | Infusion | Alfamed S.A.L. | Medac Gesellschaft Fur Klinische Spezialpraparate mbH | Germany | 5,519,927 L.L | 21.26 | C | Medac Gesellschaft Fur Klinische Spezialpraparate mbH | Germany | 2/1/2023 |
| L01XA03 | G | Oxaliplatin - 100mg/20ml | 9210 | 152816/1 | OXALIPLATIN USP INJECTION | 100mg/20ml | 1 | Injectable concentrate for solution | Infusion | Major-Pharma Drugstore | Jiangsu Hengrui Medicine Co Ltd | China | 5,715,890 L.L | 21.26 | C | Sagent Pharmaceuticals Inc | USA | 2/1/2023 |
| L01XA03 | G | Oxaliplatin - 100mg | 6383 | 218856/09 | OXALIPLATINE MYLAN 5MG/ML | 100mg | 1 | Injectable powder for solution | Infusion | Benta Trading Co s.a.l. | Benta SAL under license from Mylan S.A.S. France | Lebanon | 4,594,438 L.L | 23.08 | B | 2/1/2023 | ||
| L01XA03 | G | Oxaliplatin - 100mg | 10954 | 23122/1 | OXALIPLATINO GP PHARM | 100mg | 1 | Injectable lyophilised powder for solution | Infusion | Mediterranean Pharmaceutical Company | GP-Pharm, SA | Argentine | 4,363,644 L.L | 23.08 | B | GP-Pharm, SA | Argentine | 2/1/2023 |
| L01XA03 | G | Oxaliplatin - 100mg | 6326 | 221168/08 | OXALTIE | 100mg | 1 | Injectable lyophilised powder for solution | Infusion | New Europharm | Bioprofarma S.A. | Argentine | 4,164,050 L.L | 23.08 | B | Bioprofarma S.A. | Argentine | 2/1/2023 |
| L01XA03 | G | Oxaliplatin - 100mg | 10661 | 221168/08 | OXALTIE | 100mg | 1 | Injectable lyophilised powder for solution | Infusion | New Europharm | Laboratorio Kemex SA | Argentine | 4,164,050 L.L | 23.08 | B | Bioprofarma Bago SA | Argentine | 2/1/2023 |
| L01XA03 | G | Oxaliplatin - 100mg/20ml | 7484 | 97223/12 | OXITAN | 100mg/20ml | 1 x 20ml | Injectable solution | Infusion | Macromed S.A.R.L. | Fresenius Kabi Oncology Limited | India | 4,106,063 L.L | 23.08 | B | Fresenius Kabi Oncology Limited | India | 2/1/2023 |
| L01XA03 | G | Oxaliplatin - 100mg/50ml | 7054 | 222289/08 | X-PLAT 100 | 100mg/50ml | 1 x 50ml | Injectable concentrated solution | Infusion | Droguerie de l'Union | Cipla Ltd | India | 4,701,347 L.L | 23.08 | B | Cipla Ltd | India | 2/1/2023 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2023